Neurotech reports clinical trial results for world first Autism Spectrum Disorder drug8 July 2022 News & MediaThe SentimentThe cannabinoid based drug, licensed from Dolve Cann Global is the world’s first full-spectrum medicinal cannabis product (with less than 0.3% THC).